Do we as humans need love to survive?
There was a whole series of studies done in the 1950's with baby monkeys (Harry Harlow, Monkey Love Experiments), where they showed that raising a baby without it's mother, and with no source of affection was devastating to them. It caused permanent damage, and, in some cases, caused them to just break down and die. Note that these monkeys were well fed, cleaned, kept in a temperature-controlled environment, provided with all the necessities of life, but no nurturing affection or love. It destroyed them.
As for human studies, experimentation in naturally impossible, but there were studies done in cases where huge numbers of children were committed to government-run orphanages. The orphanages had employees to make sure the children were feed, cleaned and clothed, but they had neither the time nor the resposibility to give the children expressions of love. Those children almost universally suffered very serious psychological effects throughout their lives, and, in some cases, literally died of neglect.
Now, these are all studies of children that are still developing, but the evidence is clear that there's a basic human need for some kind of love and attachment. As we become older and more psychologically self-sufficient, we're less sensitive to such things, and can survive without any kind of love in our lives, but we're still humans and we still need human connections. It's more that a good thing to have, such is critical need in our lives.
I've read about the orphanage study, but what about adults? What happens when you pass the age where your physical survival depends solely on yourself?
I say you don't need human love (by which I mean romantic love). It's a good thing to have if you can get it, but some people can't. You have no control over whether anyone loves you.
The only unconditional love you can ever have is that of a cat or a dog, perhaps another fur-bearing mammal like a fennec fox. Feed them, play with them, and pet them and they will love you forever. They don't use people or betray them.
As long as you have good friends and loving pets you can be satisfied with life.
Yes. It's primarily feelings of love that prompt parents to care for their children. Human children have not evolved to be self-sufficient, so if their parents abandoned them, they would not survive. And if human children didn't survive, the species would die out.
Who is the most complex, well-written antihero in Marvel/DC comic books? Why?
Why is the upcoming Captain Marvel a film you can't miss?
Why is Lucifer show not on Netflix?
5100 | Will the planned sequels to James Cameron's Avatar preform as well at the box office as the original?
3085 | Will Marvel downplay Avengers: Infinity War like they downplayed Captain America: Civil War?
7738 | I am from India. What is your daily fitness routine?
1953 | Which site is the best for downloading Hindi Bollywood songs?
8148 | What would happen if Wolverine met Iron Man in The Avengers movie?
8852 | Do astronauts enjoy their jobs?
3067 | How is Indian education?
1752 | Why is J.R.R. Tolkien's Lord of the Rings considered to be such a classic?
Who would win, Superman (DCEU) vs Doomsday (DCEU)?
What character would be the heroine in the upcoming Marvel's Doctor Strange movie?
How can a 15 year old get money from programming?
Which Hindi movies have been remade into other Hindi movies?
Which Avengers movie is the best?
What should I do to be a good businessman?
Who hated Avengers 2 Age of Ultron?


Art can take many forms. Some of it is wearable; some pieces are for viewing only, and in other cases, it is also utilitarian. In the historic downtown of Rosenberg, we can thank the Rosenberg Arts Alliance for the idea of having artistically-painted benches installed throughout a six-block area.


text:
Discover A&M Music Center in Lyndhurst, N.J.
If you long for the old-school ways of buying and enjoying your music, Alan Maisano's A&M Music Center in Lyndhurst, N.J., is right up your alley.
Goldmine staff
LYNDHURST, N.J. — If you long for the old-school ways of buying and enjoying your music, Alan Maisano's A&M Music Center is right up your alley.
Don't go looking for social media posts or a web site; what you need to see and do can be done at the store or working directly with Maisano. He's happy to help you track down that hard-to-find record you've been seeking. And special orders are always welcome.
Most of all, Maisano enjoys providing the in-person, brick-and-mortar record shop experience to customers at the 238 Stuyvestant Ave. shop. When Maisano opened A&M Music Center last fall, he had one heck of in-store guest come by to help celebrate: guitarist Frank Iero of My Chemical Romance fame. Maisano was Iero's history teacher back in the day at Queen of Peace High School in nearby North Arlington, N.J. The pair bonded over a love of music — both play guitar — and had started a music club together at the school.
One more modern trend Maisano has eagerly embraced is Record Store Day. His shop is participating in 2014 Record Store Day events on April 19, 2014, which also will include a 3 p.m. performance by The Captain and O'Neill.
Here's the scoop on Alan Maisano and his A & M Music Center.
Q: What was the first record you ever bought?
A: The Byrds, "Fifth Dimension."
Q:When did the idea of owning your own record store first occur to you?
A: A lifelong dream!
Shoppers flip through the bins at A&M Music Center, Lyndhurst, N.J., at the shop's grand opening event on Sept. 3, 2013. Photo courtesy Alan Maisano.
Q: What is the history of your store?
A: We opened up on Sept. 3, 2013 with Frank Iero (My Chemical Romance) making a personal appearance and performing in the store.
Q: What do you carry/specialize in?
A: Records, CDS and DVDs. Classic rock: 1960s, 1970s. Special orders are welcomed. Hard-to-find items is our specialty. Stop by monthly for in-store promotions!
Q: What changes have you noticed in the music retail market over the years? What trends have you noticed in terms of vinyl-record sales?
A: People are going back to purchasing vinyl! Sales of vinyl have increased, while sales of CDs are down.
Q: What does your store offer that few, if any, others do?
A: Special orders for hard-to-find items that even the larger chain stores are unable to get! Every month we feature new promotions and a concert by local and national recording artists.
Q: How do you feel about Record Store Day?
A: This upcoming Record Store Day, we will feature colored vinyl, picture discs and rock star autographed photos.
(RELATED ARTICLE: Click here to see the full list of 2014 Record Store Day releases.)
Alan Maisano keeps guests company as they wait to meet Frank Iero of My Chemical Romance fame (right) during the grand opening of Maisano's record shop, A&M Music Center, in Lyndhurst, N.J. Photo courtesy Alan Maisano.
Q: What was the biggest day the store ever had (so far, of course!)
A: The grand opening. Over 400 people showed up because of the personal appearance and performance by Frank Iero.
Q: What do you think is the future of record stores like yours?
A: I believe that record stores will experience an upturn, because more and more people are interested in vinyl.
Q: What's the rarest record you've ever had in your store?
A: The Masked Marauders, which was a hoax perpetrated by Greil Marcus of Rolling Stone magazine in which it was believed that John Lennon, Paul McCartney and Mick Jagger, among others, were present on the album.
Q: What's the strangest request you've ever gotten from a customer?
A: Sir Lord Baltimore, and I was able to get both of the albums that the customer requested!
Q: What advice would you have for people who want to own a record store?
A: If that is your dream, DO IT!
Q: Now for a little fun: Mono or stereo?
A: Mono AND Stereo!
Q: Fat Elvis or Skinny Elvis (music only)?
A: All Elvis Stuff is Great!
Q: Vinyl or CD?
A: Vinyl rules!
Q: George Harrison or Eric Clapton?
A: Eric Clapton AND George Harrison! GM

redpajama_set_name: RedPajamaCommonCrawl


text:
Q: How do I load an image/byte array in Razor Pages I'm trying to have a page load an image from the database using @Url.Page. I can see it hits the PageModel handler method, but the image is never visible.
Everything I've found relates to Razor views with MVC. I'm specifically working with Razor Pages and do not have controllers, just Page Models.
Page:

                  Existing Image:

Page Handler method:
        public async Task<IActionResult> OnGetFilePreview(int imageFileId)
        {
            // Get Image File from database
            File imageFile = await _fileService.GetFileById(imageFileId);

            return File(imageFile.FileContent, imageFile.MimeType, imageFile.FileName);
        }

A: I test with my project,it can work,you need to make sure the file you returned is correct.Here is a demo:
View:

handler(I test with a file in wwwroot):
public async Task<IActionResult> OnGetFilePreview(int imageFileId)
        {

            string path = Path.Combine(Directory.GetCurrentDirectory(), @"wwwroot\imgs\1.jpg");

            byte[] bytes = System.IO.File.ReadAllBytes(path);
            return File(bytes, "application/octet-stream", "1.jpg");

        }

result:

A: So it turned out that the code I had written was fine, and that the data I was saving in the database and thus returning was not a byte array, and instead a Base64 string.If someone stumbles on this question, the method I've used to display an image from the db saved as a byte[] ashould work fine.

redpajama_set_name: RedPajamaStackExchange


Taking on the American-extremist role was the Boyle�s next-door neighbor, Ralph, who would wear army fatigues and a full magazine of bullets as he hid in the bushes for fear of an enemy attack. The show also featured a number of celebrity spots, with guest voices coming from comics like Phyllis Diller, Jonathan Winters, Don Knotts and Rich Little.
It was first a pilot on "Love American Style" in 1972.


text:
Q: Small gap between image and image border on chrome & edge desktop I am getting some strange behaviour aligning images within a border on Chrome (Version 93.0.4531.2) and Edge (Version 91.0.864.37) on desktop (Windows 10 20H2, macOS Big Sur 11.3.1). This is not an issue on mobile.
Please refer to the images to see the small gaps. It is very temperamental, since on some cards these appear on the left side, on others on the top, on some on both and on others not at all.

So far I have tried (in various permuatations):

*

*margin: 0

*padding: 0

*display: block

*vertical-align: bottom

*vertical-align: top

*vertical align: -webkit-baseline-middle
My zoom is set to 100%. Here is the code for my most recent attempt. I am using Vuejs for this project.
vue template:

base.scss
* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

component scss:
.card {
  width: 240px;
  margin-bottom: 25px;
  img {
    width: 240px;
    height: 240px;
    vertical-align: -webkit-baseline-middle;
    object-fit: cover;
    border: 1.5px solid black;
  }
}

See the behaviour live here: https://www.sableradio.live/shows. Any help would be greatly appreciated, thanks in advance.

A: you can solve this by simpley remove float number from border css property like this  for reff. attaching image screenshot
 .card {
  width: 240px;
  margin-bottom: 25px;
  img {
    width: 240px;
    height: 240px;
    vertical-align: -webkit-baseline-middle;
    object-fit: cover;
    border: 1px solid black;
  }
}

A: I was facing this issue recently.
Although I cannot figure out the root of the problem, I discovered some tricks which you may consider:

*

*setting a background to container, let the bg-color blend into the gap

.card {
  background-color: black;
}

OR

*negative margin to your photo

img {
  margin: -1px;
}

Not pretty, but it works for me.


THE Smithsonian Institution has a photography collection of more than 13 million images. The sheer size is difficult to grasp, but even more brain-numbing is the institution's balkanized method of organization: the photographs are spread across its 19 museums in 700 archives and special collections.
There is no central department for locating images by photographer, subject or theme for the artwork. But an online project, the Smithsonian Photography Initiative, intends to change that. It features a search engine that will eventually give visitors access to all the photographs in the collection, as well as offer curated exhibitions, public forums and educational programming.
Until now, a search for pictures of the 19th-century American West by William Henry Jackson, say, would lead a scholar on a scavenger hunt through the National Museum of Natural History, the Smithsonian American Art Museum and the Freer Gallery of Art and the Arthur M. Sackler Gallery. Even then, the process might yield only a fraction of the Jackson images held by the Smithsonian.
The centerpiece is an interactive feature called "Enter the Frame" (photography.si.edu/participate.aspx). Besides being able to search the photography collections, of which 3,000 images have been scanned in so far, the feature is meant to provide a more subjective and spontaneous way for visitors to view the art: browsing images, looking at them sequentially and keywording, or tagging, them for themselves and other viewers.
This month, the site inaugurates "Click! Photography Changes Everything," (click.si.edu). an online publication and forum.
To do so, 100 contributors were invited to describe how photography has affected them and influenced the disciplines they represent. Their comments are presented alongside images selected from the collections.
The contributors include not only curators and researchers at the Smithsonian, but also a geographer from Vassar who talks about photography and the landscape; a doctor from Harvard who discusses photography and doctor-patient relationships; a financial analyst who describes its impact on financial markets, and a law professor from Columbia who cites the use of photographs as legal evidence. Hugh Hefner even discusses photography and sexuality.
The Smithsonian was primarily a scientific institution when it was founded in 1846. It hired photographers to document expeditions, record experiments, catalog indigenous people and make facsimiles of physical objects too large to store.
In the 1870s, photographers like Timothy O'Sullivan and John K. Hillers accompanied the United States Geological and Geographical Survey of the Territories authorized by Congress, documenting the American West. Not only did these images act as scientific records, but they were also used as public relations tools showing the majesty of the landscape.
Some of them were works of art in their own right. O'Sullivan's "View of a Three-Masted Sailing Ship" (1870) in Panama (taken as part of another expedition by the United States Navy), and Hillers's "View From Above of River" (Grand Canyon), 1872, are two images of geological record known for their aesthetic properties as well. Both reside in the National Museum of Natural History archives.
The Smithsonian collection has countless other gems in its archives to be mined if you know where to find them. The Hirshhorn Museum and Sculpture Garden, it turns out, has the largest public collection of Thomas Eakins's photography. Photographs by Julia Margaret Cameron, Hill and Adamson, Henry Peach Robinson, Edward Steichen and Alfred Stieglitz are represented in the collections, too.
Educational programming on the Web site is currently geared to students from kindergarten through high school. "Every Picture Has a Story: History Through Primary Sources," a feature that is in the works, will present photographs with their back stories to underscore their historic, anthropological and even anecdotal significance.
The 1870s albumen print portraits of the Emperor and Empress Meiji, for example, by Uchida Kyuichi, reside in the Freer Gallery archives. In sharp contrast to the world of celebrity images today, commoners in Japan were forbidden to see the faces of the imperial couple, who were considered deities. In their era, these photographs were never shown to the public.
But the Meiji period set off a shift toward modern ideas in Japan, and in 1899, a new set of portraits of the imperial couple, also by Kyuichi, were distributed to painters and printers to create secondary images for the public to view.
Another picture, "Picnic Group, Highland Beach, Md." (circa 1931), shows 21 young African-American girls and women dressed for the shore posing in and around a convertible. A lone man in shirt and tie stands next to the driver's seat.
The picture introduces the work of Addison N. Scurlock, a photographer who had a portrait studio in Washington's segregated black community. He documented the activities and organizations of the black middle class during the first half of the 20th century, and the Scurlock Studio Collection is housed in the archives of the National Museum of American History.


JEFFERSON CITY, Mo. — Poplar Bluff had 10 track and field athletes earn a top-five finish at Saturday's 60th annual Capital City Relays.
Paige Bradley, Jaden Deaton and Kendrick Brown all finished in third place to lead the team.
Bradley got third in the pentathlon with 2,375 points. Deaton took third in the 1600-meter run in 4 minutes, 33.71 seconds and Brown got third in the high jump after clearing 5-feet, 10-inches.
Katie Pattillo took fourth in the 100 in 13.42 and fifth in the 200 in 27.53.
Gage Rowland also picked up a top-five finish in the pole vault with a height of 13-6.
The boys 4x100 team took fourth in 45.81, and the girls' team also got fourth in 51.66. The boys' sprint medley relay took fourth in 3:42.12 and the distance medley relay got fourth in 11:13.53.
Emilee Cheek took eighth in the 100 in 13.76 while Kennedy Rowland was 13th in the 200 (28.85) and 22nd in the long jump (13-9.50) while Kenya Jones was 22nd in the 300 hurdles (55.85).
For the boys, Austin Tinsley finished 10th in the 100 (11.65) and recent Mineral Area commitment Dylan Cisne finished 12th in the 3200 (10:42.81).
Jadarius Pigg finished eighth in the 110 hurdles (16.01) and seventh in the 300 hurdles (43.16). John-Paul Godwin was 17th and 21st in the same events in 17.95 and 46.53 seconds, respectively.
Chad Casey took 10th in the triple jump (38-5.00) and 13th in the long jump (18-5.50). Luke Barousse was sixth in the pole vault (12-6.00) and Preston Taylor finished 10th in the shot put (43.5.50).


text:
Q: sqlalchemy: null comparison commutativity I just stumbled upon this behaviour of sqlalchemy:
>>> from sqlalchemy import Column, null

>>> print(Column("x") == null())
x IS NULL
>>> print(Column("x") == None)
x IS NULL

>>> print(null() == Column("x"))
NULL = x
>>> print(None == Column("x"))
x IS NULL

Can someone explain why == is not commutative for null() while it is when using None? What's the purpose?

A: To begin, take a look at Identity vs. Equailty for an explanation on why your None conditions are both returning x IS NULL.
The reason why your null() clauses are returning different results is due to how the operators work.
As per the documentation, the operators work like the following:

In a column context, produces the clause a = b. If the target is None, produces a IS NULL.

Explanation:
Column("x") == null() # a = b -> b is NullType; returning IS NULL

null() == Column('x') # a = b -> b is ColumnType; not returning IS NULL

For more information, you may view the Sqlalchemy Docs


RACT is committed to ensuring Tasmania's roads are safe and accessible for all road users, enabling them to navigate the state with ease.
made by the Tasmanian Government ahead of the 2018 State Election.
RACT will keep track of the Government's commitments and ensure they deliver on their promises for Tasmania.
data, Australian Road Assessment Program (AusRAP) data and RACT Advoacy Advisory Committee input.
$4 million for planning and preparation of upgrade of Bass Highway between Deloraine and Latrobe.
2 Bass Highway (Parramatta Creek) New passing lanes Included in a $20 million co-funded project to improve safety between Deloraine and Latrobe.
4 Bass Highway (Wynyard to Marrawah) Funding for safety upgrades $40 million from the Tasmanian Government and $60 million from Federal Government to improve this section of highway. $100 million co-funded over the forward estimates under the Roads of Strategic Importance package.
$30 million Hobart Airport Interchange with Australian Government support.
Tasman Highway between Tasmania Golf Club and airport roundabout ($5 million).
Midway Point interesection solution ($7.5 million).
Overtaking opportunities on Arthur Highway ($5 million).
Southern Sorell bypass ($9 million).
Feasibility study for duplication of Tasman Highway between Hobart and Sorell ($500,000).
Airport funding of $24 million from Federal and $6 million from State.
South East solution funding of $21 million, without Tasman Highway duplication costings.
Total of $130 million from the Federal Government towards Hobart-Sorell corridor from the Roads of Strategic Importance package.
Fifth lane on Southern Outlet ($35 million).
Range of projects on Davey and Macquarie Streets ($16 million).
Establishment of a Traffic Incident Response Team ($1.2 million).
Bus priority measures ($1.2 million).
Planning to relieve pinch points ($625,000).
Progression of a Bus Transit Centre concept ($750,000).
Develop a Greater Hobart Transport Masterplan (uncosted).
$30.8 million budgeted over 4 years for Greater Hobart Traffic Vision.
$25 million towards Hobart Congestion Package.
$10 million for Tasman Highway Intelligent Transport Solutions.
Code of Practice introduced on May 7, 2018 with full compliance expected by June 30.
3 Fix congestion in Hobart and Launceston Develop long-term congestion strategies Greater Hobart Traffic Management. $30.8 million budgeted over 4 years for Greater Hobart Traffic Vision.
Invest in charging stations and incentive programs $250,000 to support the rollout of charging stations. Funds committed in current budget and forward estimates.
11 Safe driving campaigns for tourists Establishment of educational resources for domestic and international tourists focusing on the mode of arrival  Website launched in Feb 2018.


text:
Select an Event WCLC 2021 TTLC 2021 WCLC 2020 - Virtual Presidential Symposium WCLC 2020 TTLC 2020 LALCA 2019 NACLC 2019 WCLC 2019 MESO 2019 ELCC 2019 SCLC 2019 ACLC 2018 WCLC 2018 ELCC 2018 WCLC 2017 ELCC 2017 WCLC 2016 WCLC 2015 WCLC 2013
Track / Category
J. White
O26 - Support and Palliation II (ID 140)
Event: WCLC 2013
Type: Oral Abstract Session
Track: Nurses
Presentations: 8
Moderators:J. White, Y. Lai
Coordinates: 10/29/2013, 16:15 - 17:45, Bayside 104, Level 1
O26.01 - The impact of the lung cancer clinical nurse specialist on access to anti-cancer treatment (ID 1018)
16:15 - 17:45 | Author(s): A.M. Tod, A. McDonnell, J. Redman, J. White, D. Borthwick
The National Lung Cancer Audit (NLCA) (NHS Information Centre, 2011) reports annually on services provided to 38,000 lung cancer patients in the nited Kingdom (UK). The 2010 NLCA reported that only 58% of lung cancer patients in England and Wales received active treatment (chemotherapy, surgery and radiotherapy), with only 14% of patients receiving surgery. Lung Cancer Nurse Specialists (LCNS) make an important contribution to patient care and patient experience and their input is captured in the audit. The 2010 NLCA revealed a possible association between access to a LCNS and access to treatment: 64% of patients seen by a LCNS received anti-cancer treatment compared to 30% of those who did not (Ford, 2011, The Lancet 2011). The reason for this observation cannot be ascertained from the NCLA data. Thus investigation outside of the audit is required. This study begins that process using case study methodology. The study is funded by a grant from the General Nursing Council Trust. The aims of this study are to explore the role of the LCNS within the lung cancer multi-disciplinary team (MDT), identify ways the LCNS can increase treatment access for people with lung cancer and generaterecommendations for MDTs and for future research.
A collective case study, comprising four individual LCNS in four different lung cancer MDTs (McDonnell, 2012, Stake 1995). LCNS cases were selected on the basis of variation in access to treatment rates and access to a LCNS according to the NLCA data. The four LCNSs also had different models of working within the MDT and patient pathway. Methods included in-depth individual interviews with the LCNS and clinical lead plus four other MDT members, giving a total interview sample of 24. Observation of practice and documentary analysis were also used. Findings will be tested further in group interviews over the summer.
These findings provide insight into how the LCNS works across the patient pathway to influence access to treatment, while maintaining patient preference as central to practice. The findings are presented here in four themes: practice approaches, people, places and facilitators, with illustrations of how factors combined to increase or decrease access to treatment. Approaches to LCNS practice identified in the study included negotiating, brokering and co-ordinating in order to maximise treatment access and maintain patient focus. The range of people and places the LCNS works with across different disciplines, services and health sectors means they become the lynchpin to clinical treatment decisions. The study indicates how workload, relationships, job security and organisational structures operate as key facilitators to effective treatment decision making
This in-depth qualitative study provides valuable insights into the complex landscape that MDTs operate within and helps to explain why the observed association between seeing a LCNS and access to treatment may occur. The study illustrates the value of qualitative research in understanding quantitative data such as that generated by national registries and audits. Recommendations for MDTs and data capture in the NLCA audit are considered.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.
O26.02 - Understanding the Value of Lung Cancer Nurse Specialists (ID 2243)
16:15 - 17:45 | Author(s): J. White
The UK National Lung Cancer Forum for Nurses together with the Roy Castle Lung Cancer Foundation have produced a report which aims to showcase the difference Lung Cancer Nurse Specialists (LCNS) make to the lives of patients with lung cancer and their families. Eleven recommendations were made after an examination of peoples experiences of care delivered by LCNSs in addition to LCNSs own accounts of how they help to improve patient outcomes. The recommendations, combined with existing evidence of the positive impact of LCNSs on patient experience from the Cancer Patient Experience Survey and outcomes shown in the National Lung Cancer Audit, builds a compelling picture of the positive value of LCNSs. The report is called Understanding the Value of Lung Cancer Nurse Specialists.
The National Lung Cancer Audit data was used to gather information about whether patients had been seen by a LCNS and at what point in their pathway. A survey was conducted of patients with lung cancer and their carers with the aim of uncovering people`s experiences of the care delivered by LCNS. A survey of LCNS own accounts of how they help to improve patient outcomes was also undertaken. Information was taken from the Cancer Patient Experience Survey in England to assess the influence that Clinical Nurse Specialists had on the patient`s experience of care. Evidence was analysed from a number of different sources to highlight the potential efficiency savings that LCNS could make due to their role.
Results from the Cancer Patient Experience Survey showed that one of the most important findings being that those patients with access to a CNS gave more positive scores of experience than those without. When considering efficiency savings, one study found that service improvments along the lung cancer pathway led by LCNS could release about 10% of cancer expenditure in the area. The National Lung Cancer Audit revealed that around two thirds of patients seen by a LCNS went on to receive active treatment compared to less than a third who did not see a LCNS who were given active treatment.
Recommendations from the report
1 LCNS should be involved in the pre-diagnostic phase of care of suspected patients with lung cancer
2 All national clinical guidelines on lung cancer treatment should reflect the important role played by LCNS
3 NHS Commissioners / providers should ensure that there are sufficient numbers of LCNS
4 All patients should have equitable access to a LCNS at the time of diagnosis
5 LCNS posts should be protected to ensure that patients and their families are offered adequate support
6 LCNS should be provided with necessary resources to aid smoking cessation
7 More research should be undertaken to understand the reasons for the correlation between LCNS input and receipt of active treatment
8 LCNS follow up after treatment should be offered to all patients
9 LCNS should be encouraged to offer nurse led clinics
10 LCNS should be recognised as the patient`s advocate at multidisciplinary team meetings to deliver patient centered care
11 Patients with lung cancer should have access to a LCNS at all stages of their pathway including end-of-life care
The report examines the information made available and the role of the LCNS with the aim of helping to understand that vital contribution they make to the delivery of high quality care and to improved outcomes for patients with lung cancer. The report can be found at http://www.roycastle.org/Resources/Roy%20Castle/Documents/PDF/UnderstandTheValueOfLungCancerNurseSpecialists_V03.pdf
O26.03 - Is early integration of palliative care for patients with incurable lung cancer acceptable to Australian healthcare professionals? (ID 2596)
16:15 - 17:45 | Author(s): L. Mileshkin, B. Le, K. Doan, O. Spruyt, M. Conron, D. Gunawardana, S. Carvosso, D. Saward, J. Philip
In a recent landmark US study, metastatic NSCLC patients who received palliative care from the time of diagnosis concurrently with standard oncology management reported improvements in quality-of-life, symptom control, reduction in "aggressive therapies" at end-of-life, and a survival advantage compared to those receiving standard oncology management alone. The aim of this qualitative sub-study was to explore Australian health care professionals' perceptions of early integration of palliative care for patients with incurable lung cancer.
Members of the lung cancer multi-disciplinary teams of three large metropolitan teaching hospitals in Melbourne were invited to attend a focus group discussion. Data from focus groups were supplemented with interviews from a purposive sample of individual health care providers who were unable to attend the groups. Participants were asked to describe barriers and facilitators to implementation of a model of early integration of palliative care.
Three focus groups and six individual interviews were conducted with 28 health care professionals. Key facilitators and barriers to referral (see table) were grouped into 4 themes: 1. Trust; 2. Care Coordination; 3. Ease of Referral; and 4. Perceived patient/family reaction.
Issues discussed as facilitators / or barriers
Trust 1. Confidence in the quality of the palliative care service 2. Palliative care poses a threat to the referrer 3. Past experience with community palliative care
Care Coordination 1. Integration of concurrent palliative care and "active treatment" 2. Concern about adding to fragmented care and lack of co-ordination 3. Effective Communication between care providers
Ease of Referral 1. The value of a physical presence of the palliative care provider in the clinic 2. Perception of limited resources
Perceived patient/family reaction 1. Cultural perceptions about what referral to palliative care means 2. Concern about patient and/or family reaction to referral leading to distress and loss of hope
Early involvement of palliative care in patients with incurable lung cancer is acceptable to the majority of treating clinicians. Palliative care services must be embedded into the system, sufficiently resourced and of high quality. For early referral to occur the model ideally involves a physical presence of a palliative care clinician in clinic who is easily accessible for referrals and considered a core team member.
O26.04 - DISCUSSANT (ID 4010)
16:15 - 17:45 | Author(s): M. Duffy
Abstract not provided
O26.05 - Patterns of care in palliative radiotherapy delivery in advanced lung cancer: How has this influenced the development of a Palliative Radiotherapy Rapid Assessment Clinic (PRRAC)? (ID 3060)
16:15 - 17:45 | Author(s): K. Pope, C. Liu, N. Michael, C. Fitzpatrick, A. Rutyna, W. Poon, J. Vassie, J.H. Foo
Radiotherapy (RT) is a clinically and cost effective modality of treatment for symptom palliation. It plays a significant role in advanced lung cancer, by providing relief from symptoms such as haemoptysis and bone pain, as well as preserving neurological function in patients with brain metastases or spinal cord compression. The standard clinical approach for RT may require multiple attendances for consultation and planning, followed by a waiting period for treatment. However, patients with advanced lung cancer presenting for palliative radiotherapy are often of poor performance status with limited life expectancy. Prompt and streamlined RT is required to improve the experience of care for these patients. The Palliative Radiotherapy Rapid Assessment Clinic (PRRAC) was developed as an innovative and sustainable clinic to align consultation, planning and treatment within a single visit to facilitate efficient access to palliative radiotherapy for patients with advanced lung cancer. The PRRAC aims to i) increase accessibility of palliative RT for symptomatic patients with lung cancer, ii) reduce waiting times and iii) improve patient and referrer satisfaction.
A retrospective audit of symptomatic patients with lung cancer who received low dose palliative RT from June – November 2012 at Peter Mac, East Melbourne was performed. Patient demographics, dates of initial clinic, planning and RT commencement, and RT dose fractionation schedules were collected. A service model (PRRAC) was developed based on the adaptation of similar clinics in operation in Canada and Brisbane, Australia. The proposed PRRAC will be piloted for 6 months. Eligibility criteria include those patients with symptomatic locally advanced or metastatic lung cancer who require low dose simple RT techniques. Service utilisation and average waiting times will be compared to previous patterns of care. Patient outcomes and surveys of referring physicians will be evaluated prospectively. Overall utilisation of the service will help assess clinical need & sustainability.
The retrospective audit has demonstrated 79 patients with lung cancer who were prescribed low dose palliative RT. The mean age was 70 years and 17% of patients were ECOG status >3. The mean waiting time from initial clinic assessment to planning was 3.6 days (SD 3.7), and from planning to RT commencement was 5.4 days (SD 5.1). 48% of patients were prescribed a single dose of RT. The early results and challenges in developing the prospective PRRAC as a new model of care for patients with lung cancer will be presented.
The PRRAC is expected to improve access of patients to palliative radiotherapy, and shorten waiting time from clinic to RT commencement date with less visits and potentially shorter dose fractionation schedules. It is anticipated that PRRAC will also improve patient and referrer satisfaction. Following successful completion of the project, the PRRAC will be embedded into clinical practice, and extended to other tumour streams.
O26.06 - Impact of geriatric assessment on treatment decisions in older lung cancer patients. (ID 1419)
16:15 - 17:45 | Author(s): L. Vanacker, C. Kenis, K. Van Puyvelde, J. Flamaing, D. Schallier, J. Vansteenkiste, G. Conings, K. Nackaerts, J.P. Lobelle, K. Milisen, J. De Grève, H. Wildiers, L. Decoster
This study aims to investigate the influence of a geriatric assessment (GA) on cancer treatment decisions in older lung cancer patients (pts). We also studied the changes in functionality during treatment and the occurrence of severe chemotherapy-related toxicity.
For this analysis, we selected the lung cancer cohort that was part of a larger study on GA in older cancer pts in 6 tumor types in two Belgian university hospitals[1]. Between July 2009 and September 2011, pts aged 70 years or older with a newly diagnosed or progressive lung cancer were evaluated at baseline using a uniform GA including geriatric screening with G8 and the Flemish Triage Risk Screening Tool (fTRST), pain, social data, Activities of Daily Living (ADL), Instrumental Activities of Daily Living (IADL), fall history, Mobility-Tiredness Test (MOB-T), Mini Mental State Examination (MMSE), Geriatric Depression Scale (GDS-15), Mini Nutritional Assessment (MNA), ECOG-Performance Status (ECOG-PS), Charlson Comorbidity Index (CCI) and poly-pharmacy assessment. GA results were communicated to the treating physician and, after the treatment decision, the physician was interviewed using a predefined questionnaire focusing on unknown geriatric problems revealed by GA and impact on cancer treatment decisions. Between two and three months of follow-up, functionality was reassessed and severe toxicity in pts receiving chemotherapy was recorded.
Seventy three lung cancer pts were included with a median age of 76 years; 82.2% were non-small cell lung cancer (NSCLC) and 74% were stage IV. Treatment was modified from standard according to standard clinical assessment (including age) in 56.1%. GA revealed unknown geriatric problems in 25.8% of cases, leading to a geriatric intervention in 10.6%. 30% of physicians consulted the GA before final treatment decision and in three pts (4%) only this led to a modification of the proposed treatment: dose reduction, no chemotherapy or no radiotherapy. At follow up (n=50), functional decline was observed in 24% and 54% of pts for ADL and IADL, respectively. Grade III-IV toxicity occurred in 14/42 pts treated with chemotherapy (33%), mainly non-haematological (64%).
This analysis indicates that the treatment of older lung cancer pts is often influenced (deviated from standard) by standard clinical assessment and age. Although GA revealed previously unknown information in 25.8% of pts, only a minority of physicians consulted these results before the final cancer treatment decision. There was little impact on geriatric intervention and even less on cancer treatment decision. This discrepancy reveals the need to get physicians treating lung cancer acquainted with GA and geriatric interventions in an attempt to decrease chemotherapy related toxicity and improve quality of care. Further evaluation of GA and geriatric interventions in larger pt groups as well as their implementation in clinical practice is warranted.
O26.07 - Towards Cancer Rehabilitation at Home<br /> Design of a Telerehabilitation Service for Lung Cancer Patients (ID 2697)
16:15 - 17:45 | Author(s): J.G. Timmerman, T.M. Tönis, M.W.J.M. Wouters, M.G.H. Dekker-Van Weering, H.J. Hermens, M.M.R. Vollenbroek-Hutten
Although lung resection still provides the best long-term outcome for lung cancer, it is also associated with a considerable decay in physical and psychosocial health status[1,2]. If not controlled, these symptoms can hamper postsurgical recovery, and lead to unscheduled healthcare use[3]. This study aimed to determine the clinical relevance of and functional requirements for a telerehabilitation (TR) service to support recovery following lung resection.
A sociotechnical scenario-based design approach was used, characterized by early and systematically involvement of patients and healthcare providers during an iterative design process (figure 1). First, end users' requirements for the TR service were explored by means of semi-structured interviews. Subsequently a small focus group with healthcare providers from the Netherlands Cancer Institute – Antoni van Leeuwenhoek hospital (NKI-AVL) in Amsterdam was organised to establish requirements for the TR service in more detail. The findings from the interviews and focus group were summarized in a scenario and validated by healthcare professionals from the NKI-AVL. Figure 1
Survivors and professionals expected a TR service to be beneficial for improving quality of current care, and identified three modules that should be included in the TR service: ambulant monitoring of recovery and symptoms, home exercise programs and patient-provider contact. The functional requirements for these three modules and general requirements as reported by the patients and professionals are presented in table 1. The results also indicated that successful implementation of the service will be promoted by structurally embedding the service in existing healthcare processes, and record clearly the specific roles and responsibilities of all involved healthcare professionals. Figure 1
End-users showed positive intention to use a TR service for home-based symptom monitoring and rehabilitation. At this moment, a prototype of the TR service is designed, which will be evaluated this summer in patients and healthcare providers to improve end-users' acceptance.
16:15 - 17:45 | Author(s): P. Yates
GR02 - Is There a Role for the Thoracic Oncology Nurse in Ensuring Patients with an Advanced Lung Cancer have Access to Early Phase Clinical Trials? (ID 17)
Type: Grand Round Session
Moderators:C. Broderick, M. Hesdorffer
Coordinates: 10/29/2013, 10:30 - 12:00, Bayside Gallery A, Level 1
GR02.2 - Affirmative (ID 452)
GR02.3 - Negative (ID 453)
Cancer is the leading cause of death in the world, accounting for approximately 7.6 million deaths in 2008. Lung cancer accounted for 1.37 million of those deaths.Identification of molecular markers in lung cancer has lead to the development of targeted therapies resulting in improved survival in selected groups of lung cancer patients. Despite the advancements in treatments, the survival for patients with lung cancer, particularly in the metastatic or locally advanced patients (stage IIIb/IV), is generally poor with a 5-year survival of only 6%. The current poor prognosis and latest advances made in the field of lung cancer highlight the importance of clinical trial development, participation and analysis. Participation in clinical trials for the general cancer patient's is low, between 5-9%. This low percentage is similar to those seen for lung cancer patients. Early stage clinical trials have a smaller number of participants by design and are aimed at establishing a maximum tolerated dose of a drug or treatment, not establishing efficacy.These clinical trials are not designed with curative intent but rather are designed to evaluate drug absorption, distribution, metabolism, excretion and mechanism of action. Only a small number of cancer patients and even a smaller number of advanced stage lung cancer patients enroll into phase I clinical trials. The number of international clinical trials has seen a rapid increase over the past decade. Recently the Office of Inspector General (OIG) reported that as of 2008, 80% of marketing applications for drugs and biologics approved by the US Food and Drug Administration (FDA) contained data from US clinical trials conducted outside of the USA. Despite the importance and availability of clinical trials for lung cancer, participation in early stage clinical trials by advanced stage lung cancer patients remains very low. There are multiple barriers that contribute to these low numbers of participants, some of which include: (1) fear of unknown benefit from the investigational treatment, (2) negative family and family physician influence, (3) logistical and attitudinal constraints – too cumbersome to participate and not willing to be the subject of "experiments", (4) lack of knowledge, understanding and fear of the complexities of the clinical trial, (5) risk of inability to tolerate related investigational drug / treatment toxicity due to more weaken condition and (7) financial and insurance barriers.Identifying and overcoming the barriers that exist for each patient early in their diagnosis has the potential to improve both the quality and quantity of their lives and potentially help others with the same barriers in the future. Another significant barrier is the real and perceived conflict that exists between the need for palliative and/or Hospice levels of care for advanced stage lung cancer patients. The need for Hospice benefits and palliative care can and does have a significant impact on the decision to participate in early stage clinical trials to the point that participation may not even be an option. Funding and other system related issues act as barriers to participation in early stage clinical trials as well as the philosophical basis of the hospice/palliative care approach to treatment/care. Over the past decade the availability of symptom management and palliative care clinical trials has increased the awareness of this barrier and in many respects further clouded the issue for patients, their families and their healthcare providers. The primary ethical concern is does enrollment into clinical trials interfere with the spirit of hospice care or does it offer hope to a dying patient? Identifying issues that exist globally may help to increase enrollment by advance stage patients while at the same time moving early phase clinical trials forward and onto the phase II/III stage of study. Phase I trials are not designed with curative intent and phase I agents are not likely to prolong life or change the course of a disease. The life expectancy of phase I cancer patients' averages between 5-6.5 months. Hospice providers and research investigators are in agreement that phase I clinical trials should be open and available to advanced stage lung cancer patients who are concurrently enrolled in hospice care. Overcoming the barriers and obstacles for advanced stage lung cancer patients to participate in early stage clinical trials can only happen in the setting of a committed multidisciplinary research team.Methods to utilize in an effort to move toward that goal include: (1) recognizing the importance of patient and family education, (2) recognizing the importance of healthcare provider education and awareness, (3) careful review and reinforcement of the informed consent process, (4) identifying and recognizing the potential benefit of phase I clinical trial enrollment for advanced stage lung cancer patients – clinical and altruistic, (5) recognizing and assisting patients and families with individual barriers and obstacles to participation and (6) employing effective marketing, recruiting and screening methods that are multidisciplinary in approach. Thoracic Oncology Nurses are well suited to serve as educators, advocates, resources, facilitators, and intermediaries. Nurses traditionally spend a greater amount of time in direct patient care and family interaction. Expanding and clarifying clinical information patients receive from their treating physicians is a vital role nurses play in ensuring patients are well informed and compliant with their plan of care. This is a model that can and has been extended into the realm of clinical trial work.Studies have shown that nurses play an important role in educating and recruiting cancer patients in clinical trials.A randomized clinical trial compared nurses with surgeons recruitment of patients into a clinical trial for prostate cancer and the results indicated that surgeons and nurses were equally as effective in their recruiting and educating abilities and effectiveness. With the proper education about early stage clinical trials, the conduct of clinical research, knowledge of the disease process of advance stage lung cancer and a high degree of self-motivation, thoracic oncology nurses are well suited to improve access and enrollment of advanced stage lung cancer patients into early phase clinical trials.
MO27 - Patient Centred Care (ID 141)
Type: Mini Oral Abstract Session
Moderators:C. Broderick, J. McPhelim
MO27.07 - Holistic Needs Assessment - What the patient doesn't tell us (ID 2813)
All cancer survivors should have a personalised assessment and care plan, and support to self manage their condition (UK DoH 2010) The SPARC (Sheffield Profile for Assessment and Referral to Care) is a tool designed to be completed by the patient, with support from carers if needed, and forms the starting point for the holistic needs assessment process. SPARC is a screening questionnaire that explores a variety of issues and may help the patient/carers to reflect on their needs. The SPARC assessment tool was evaluated for its application utilising lung cancer patients who attended the Lung Cancer Clinic in Rotherham from 2011-2012.
100 patients responses utilising the SPARC assessment tool were analysed at various time points of their pathway including diagnosis, post treatment, disease recurrence and 5 years post discharge.
The results analysed were in the domains of physical symptoms, communication and information issues, treatment issues, psychological symptoms and distress thermometer outcomes. Key results showed that: - all patients suffered with common symptoms from lung cancer; - were mostly concerned about the effect that their illnes was having on their family or other people; - many required input to help with their personal affairs; - psychological symptoms were evident in a significant proportion of patients; - the distress thermometer was an appropriate tool in this clinic. The results will be shown in detail in the poster.
The SPARC assessment tool is an efficient and validated audit tool for assessing patient concerns and to provide feedback to the patients healthcare team. In Rotherhamm the tool will continue to be utilised and evaluated and is offered to all patients at the first post treatment phase and when no further active treatment is planned. The tool is an appropriate audit tool for assessing patient concerns and to provide feedback to clinicians and community health care teams.
MO27.09 - Guideline for Telephone Follow Up for Patients Undergoing<br /> Thoracic Surgery (ID 1592)
Lung cancer affects nearly 41, 500 people per year in the United Kingdom (UK) of which 5000 (12%) will undergo major lung resection for primary lung cancer with approximately 15% of all patients having complications post operatively. Once the patient develops a post surgical pulmonary complication mortality increases from 0.5% to 12%, ITU admission rate increases from 1.5% to 26% and the length of stay increases from 5 to 14 days. The UK National Lung Cancer Forum for Nurses have produced a Guideline for Telephone Follow Up for Patients Undergoing Thoracic Surgery . The aim of the Guideline is to help to provide a telephone follow up service to patients to reduce rates of re-admission and to improve patients satisfaction of their care. The guideline was produced following an audit of patients who had undergone thoracic surgery and a consensus of expert opinion within the thoracic surgical speciality.
In 2012 a retrospective audit of patients who had lung surgery was undertaken by UK National Lung Cancer Forum for Nurses Thoracic Surgical Group (TSG) in 2012 to assess the timing of intervention after discharge and what assessments would be important to patients. Following a literature review, opinions gathered from Thoracic Surgeons (who worked with the TSG members) and other Lung Cancer Nurse Specialists an assessment was made on how best to support patients after lung surgery. The guideline was developed through regular meetings of the TSG and was developed following the audit, literature review and consideration of the expert views provided.
The audit data was collected from 147 patients from across four Thoracic Surgical Centres in the UK and received 439 comments and focused specifically on post-operative care. The data showed that the consensus opinion from patients was that a preferred interval for post-operative assessment by telephone was between two and seven days after discharge and provided information on the aspects of care that were important to them. The aspects of care that were important to patients included wound management, pain, breathlessness, activity, anxiety, constipation, fatigue and sleep. Following the literature review and expert opinion gathered from Thoracic Surgeons and Clinical Nurse Specialists the decision was made to produce the Guideline for Telephone Follow Up for Patients Undergoing Thoracic Surgery for which can be used by any health professional. The guideline includes assessment tools and interventions utilising best available evidence to assist in the identification of concerns or problems that a patient may face after thoracic surgery. The full guideline can be found at www.nlcfn.org.uk
This guideline aims to help support health professionals in the provision of a follow up service to patients after thoracic surgery. The audit of patients who had undergone lung surgery helped to focus on the problems that patients had identified as being important to them and, together, with best available evidence and expert consensus opinion allowed the development of this guideline. The guideline is being utilised in thoracic centres in the UK and could be adapted for use in other countries.
O07 - Supportive and Surgical Care (ID 136)
Track: Surgery
Moderators:M. Culligan, K.A. Mooney
O07.05 - Guidelines to Prepare and Support Patients Undergoing a Lung Resection (ID 101)
Lung cancer affects nearly 40,000 patients per year in the UK of which 5000 (12%) will undergo major lung resection for primary lung cancer. Approximately 15% of patients will have complications post operatively. Once the patient develops a post surgical pulmonary complication mortality increases from 0.5% to 12%, ITU admission rate increases from 1.5% to 26% and the length of stay increases from 5 to 14 days. A Lack of preparedness prevents patients immediately engaging in post operative activities successfully and can result in an increase in patient's anxiety, post operative complications and length of stay in hospital. The United Kingdom National Lung Cancer Forum for Nurses Thoracic Surgical Group (TSG) has produced this Guideline to aid health care professionals in the preparation and support of patients undergoing a lung resection with an aim to promote patient self management.
Following a literature review and discussion amongst this specialist group the Guideline was developed focusing on key topic areas and interventions which included: poor nutrition, before and during the healing process is associated with poor wound healing risks of hospital death and pulmonary complications after lung cancer resection are increased by smoking patients who receive a multi-disciplinary rehabilitation and early mobilisation achieve earlier discharge from hospital and significantly reduce in hospital morbidities and complication rates patient's satisfaction regarding pain management significantly correlates to the preoperative information they have received good quality patient information is vital in reducing patient's anxiety and improving the overall patient experience
The Guideline was developed to support any health professional involved in the provision of care for patients who are undergoing thoracic surgery. The Guideline includes information for health professionals providing examples of current best practice and information for patients. The aim of the Guideline is to support self management, support patients through the surgical pathway, and improve patient outcomes and patient experience. The full guideline can be found at http://www.nlcfn.org.uk/editorimages/Guidelines%20to%20Prepare%20etc.pdf
The Guideline is relevant to all patients who are undergoing a lung resection. The Guideline includes a series of broad statements and where necessary local procedures should be developed to complement the guidelines in each clinical area. The Guideline compliments the Surgical Follow Up Guideline also produced by the NLCFN Thoracic Surgical Group.
O19 - Support and Palliation I (ID 138)
Moderators:Y. Chen, J. Ingham
O19.02 - Developing Guidance For The Supportive And Palliative Care Of Lung Cancer And Mesothelioma Patients And Their Carers (ID 84)
Lung cancer remains the United Kingdom's commonest cause of cancer death and accounts for 1 in 14 of UK deaths from cancers. Approximately 41,428 new cases of lung cancer and 2500 new cases of mesothelioma are diagnosed in the UK (CRUK : Cancer Research UK 2009.) Evidence shows eighty per cent of people will present with advanced disease and the majority of these will die within a year of diagnosis (CRUK 2009.) There is a large amount of evidence in existence to support end of life care but this is very generic in nature. Consensus opinion from the National Lung Cancer Forum for Nurses recognised the need for specialist guidance for lung cancer and mesothelioma patients to enhance their end of life experience and to inform health care professionals who are caring for this group of patients. The focus of the project was to develop guidance driven by evidence from patients and carers, to focus on issues highlighted by them that were important. Previous guidance produced had not had this direct focus.
This guidance has been developed over an eighteen month period by a dedicated working party with expertise in caring for lung cancer and mesothelioma patients and carers and incorporating current evidence and guidance which was reviewed extensively. The document provides detailed supportive and palliative care specialist interventions to assist any health care professional who is caring for a patient with advanced lung cancer or mesothelioma. The guidance is focused around nine key elements that were identified in work carried out by the Health Experience Research Group at the University of Oxford. Cancer patients identified nine key areas of their care that were important to them or that they found to be lacking. Holistic approach to care. Getting the bad news. Care co ordination. Responsiveness and ease of access to benefits and support. Pain control and symptom management. Staff attitudes and empathy. End of life choice and the actual experience. Carer focus. Each of these nine key elements are addressed within the guidance. Recommendations are made based on evidence and specialist experience. Good practice examples are included collected from a wide range of lung cancer services across the United Kingdom to assist users to develop their own practice.
The guidance was completed and published in Novmber 2012. The guidance provides a usable document with evidence and practice examples to assist health care professonals to improve supportive and palliative care within their area. The document is being diseminated locally by specialist lung cancer nurses and nationally via the National Lung Cancer Forum for Nurses.
Although recently published and to date has not been formally evaluated, this guidance has been well received by health care professionals and organisations associated with the care of lung cancer and mesothelioma patients. References 1. Cancer Research UK (2009) : Incidences of Lung Cancer (online) Cancer Research UK. Available from 2. Health Experience Research Group (HERG) University of Oxford, GC Associates, Unpublished.
O19.05 - Guidance for the Assessment of Patients following Palliative Radiotherapy for Lung Cancer (ID 112)
Palliative radiotherapy to the thorax is very effective at managing symptoms and improving quality of life but can also have significant toxicity. Dosing decisions are a balance between potential benefit and toxicity in patients whose prognosis and performance status is poor and who are likely to have multiple co-morbidities and complex causation of symptoms. Observations made by the members of the Uinted Kingdom National Lung Cancer Forum for Nurses (NLCFN) raised concerns that this group of patients may not be receiving optimal intervention and support following palliative radiotherapy. The NLCFN has therefore produced Guidance for the Assessment of Patients following Palliative Radiotherapy for Lung Cancer to aid Lung Cancer Nurse Specialists (LCNS) in the assessment and intervention of patients undergoing low dose palliative radiotherapy for symptoms related to lung cancer and side effects from treatment.
A NLCFN working group was created to analyse the observation of sub-optimal care following palliative radiotherapy. A literature review was undertaken to identify current best evidence and practice. A survey was undertaken to question LCNS, Clinical Oncologists, as well as Radiographers who could provide whether there was a need for such a guideline. 53 responses were received. Following analysis of the survey and discussion within the working group the Guidance for the Assessment of Patients following Palliative Radiotherapy for Lung Cancer was produced. The guidance aims to aid LCNS in the assessment and intervention of patients undergoing low dose palliative radiotherapy for symptoms related to lung cancer and side effects from treatment. Table 1 Figure 1Figure 2Figure 3
Following the literature review, although there was significant evidence of toxicity profiles and effects of treatment, there were no examples of how to address the support needs of patients following palliative radiotherapy to the thorax. Of the 53 responses, 75% said that there was a need for the service, 54% were not aware of current practice in radiotherapy follow up support, with 55 % stating that a review should take place between 1 and 2 weeks after treatment. The working group produced the guideline following discussion in relation to these outcomes.
The Guidance for the Assessment of Patients following Palliative Radiotherapy for Lung Cancer aims to guide LCNS and the treating teams in the assessment and intervention of patients undergoing low dose palliative radiotherapy for symptoms related to lung cancer. The guideline contains flow charts with recommended interventions together with documentation proforma and Common Toxicity Criteria. In the UK patients are treated in Cancer Centres and often repatriated to secondary care for review and follow-up. The formal assessments provided in the Guidance can be implemented either in the clinic, telephone or home visit. The guideline could be adapted for use in other health care systems other than the UK and can be found at http://www.nlcfn.org.uk/NLCFN-guidelines.htm
P1.25 - Poster Session 1 - Nurses (ID 248)
Type: Poster Session
Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
P1.25-001 - The National Lung Cancer Forum for Nurses (NLCFN) (ID 785)
Lung cancer affects nearly 40,000 patients per year in the UK and despite recent improvements in treatments, outcomes remain poor (NCIN 2012). Therefore the delivery of high quality care is vital. Lung Cancer Nurse specialists (LCNS) are well placed to provide holistic care, ensuring needs are addressed throughout the pathway, and there is an improvement in outcomes and experience for patients. The National Lung Cancer Forum for Nurses (NLCFN) was established in 1999 and is a national organisation in the United Kingdom (UK) developed to support lung cancer nurses through education, sharing best practice and peer support through a national network. The Forum has grown inexplicably and its success can be measured by the links and networks for nurses involved in caring for people with lung cancer as well as the strategic groups it is involved with nationally and internationally. The members are from diverse backgrounds of palliative care, respiratory medicine and thoracic oncology which results in a wealth of experience and knowledge. The NLCFN has approximately 280 members.
The NLCFN runs a Research Interest Group (RIG) and a Thoracic Nurses Subgroup (TNS) and both groups are active in improving practice and initiating research projects in lung cancer. The NLCFN proactively supports nursing research and offers a small grant award scheme each year to support lung or thoracic nurses who wish to develop a research project. Collaboration between the Forum and Sheffield Hallam University has led to the development of funding for a part-time PhD studentship. The RIG has been successful in obtaining a research grant to explore in more detail the evaluation of the LCNS role in treatment access. The NLCFN also hosts a website where patients, carers and clinicians can assess up-to-date information on lung cancer management, treatments and interventions and find out about local and national services for lung cancer patients. There is a NLCFN members section which houses guidelines and relevant documents
Over the last 10 years the NLCFN has developed into a national voice on clinical and strategic issues and as such is represented on all lung cancer improvement and strategic groups in the UK. The NLCFN have produced several documents and guidelines which are available to all health care professionals.
The number of Lung Cancer Nurse Specialists has increased since the introduction of the role in 1995. They play a vital role in supporting patients and carers throughout their pathway from pre-diagnosis to end of life care and ensuring that all their needs are addressed. The NLCFN aims to provide the LCNS with a good infrastructure for networking and support as well as continually striving for better care for their patients.
P3.25-001 - Increasing research utilisation and capacity in lung cancer nursing in the UK (ID 287)
The National Lung Cancer Forum for Nurses (NLCFN) is a UK professional organization which has a membership of around 280 Lung Cancer Nurse Specialists (LCNS) who primarily with lung cancer patients. LCNSs are the multi-disciplinary team members who spend the most time with patients. Therefore they add a unique and valued contribution to the debate regarding research priorities in lung cancer. The NLCFN is committed to developing the evidence base to inform the effectiveness and quality of their clinical care. The NLCFN recognized a need to develop research skills and capacity amongst its membership and facilitate research collaborations between academics and practitioners. To this aim the NLCFN established a Research Interest Group (RIG) in 2009. This paper summarizes a research development project undertaken by the NLCFN to increase research utilisation and capacity in lung cancer nursing.
A structured approach was taken building on research into evidence utilisation in health. (Birdell et al, 2005, Tod et al 2004, Palfreyman et al 2003a/b). Research development activity focused on four key areas, roles and responsibilities, relevance, relationships and partnerships, and organisational culture.
Over a four year period the NLCFN has successfully developed its research activity and the infrastructure to support subsequent growth. Roles: The RIG is chaired jointly by a Professor of Health Services Research and NLCFN Chair. All NLCFN members are encouraged to have a role by contributing to the critical discussion regarding evidence. However, a core group of research active members take responsibility to lead on research. The RIG has provided a mechanism for the NLCFN to liaise with key national lung cancer groups and committees regarding evidence for practice and new project development, for example a current national project exploring the contribution of lung nurse specialists to clinical trial recruitment. Research relevance is guided by an on-going research prioritisation exercise. Research partnerships have been developed through shared membership of the RIG between clinical and academic staff. The partnership has fostered five applications for research funding from a range of funding organisations, two of which have been successful, one is currently in review. Funded projects include an evaluation of the LCNS role in treatment access. Another is evaluating the use of support roles in lung multi-disciplinary teams. Current applications include an analysis of treatment and health outcomes using linked national data sources. In addition a new PhD studentship has been developed through a collaboration between the NLCFN and Sheffield Hallam University. Regular meetings, good communication, sharing of good practice and support provide a culture to allow research ideas to flourish.
In four years the NLCFN has made remarkable progress regarding research development and capacity building. By taking a structured and systematic approach the outcomes have been impressive. It has supported LCNSs to be a valued partner in research prioritisation and in generating evidence to support lung cancer practice at a local and National level. The foundations for research growth have been built and an infrastructure developed to enhance future nursing engagement in research at all levels from application to leadership.


text:
camden council members
Local Planning Panels are mandatory for all councils in Sydney and for Wollongong City Council from 1 March 2018. She is a great listener and is eager to hear thoughts and dreams for the community. - and, is past President of the Association of SC Mayors (ASCM). 020 7974 2792 . Works across all council services providing specialised administrative support and information services to all 54 Councillors to enable them to be effective within their roles. He is a Past President of the Kiwanis Club of Camden and a Past President of the Kershaw County Bar Association. She is blessed daily knowing that Habitat is helping deserving families with homes and life skills. - Kershaw County Chamber of Commerce Administraton. During her tenure running the nationally acclaimed site, she developed numerous interpretive programs for the community and tourists and was a primary partner of such popular events as Revolutionary War Field Days, Jammin' in July, FireFest, History Days, and Patriots, Picnic and Pops. Not only is Camden the fastest growing Local Government Area (LGA) in Australia, it is also one of the most exciting and evolving organisations to work for, particularly if you are looking for a challenging and strategically focused career which delivers tangible results for the community all whilst working in a flexible, contemporary environment. He served as Vice-Chairman of Council during the final two years. Elections in the Town of Camden are held on the last Saturday of February each year. The Mayor and Council preside at all meetings and vote on all matters brought before the Town Council. She retired as manager of quality and training from E. I. duPont de Nemours & Company, Inc., Lugoff, South. Phone. in psychology at the University of South Carolina. Jeffrey and his wife, Sara, are the proud parents of a son, Edwards, and daughter, Bailey. He is committed to moving the City forward–to reignite its place as a strong economic, cultural and governmental player in the region. 020 7974 5915. 1000 Lyttleton Street Details. While president of the Kershaw County Historical Society, she was editor of the award-winning Decorative Arts of Camden and Kershaw County. He was born and raised in this historic city and remains deeply engaged in the life of his community. The City of Camden, Arkansas is chartered under the Statues of the State of Arkansas and is organized under the Mayor-Aldermanic form of government. After receiving his undergraduate degree from Furman University, Smoak attended the University of South Carolina School of Law. In 2007, she testified before the U.S. House Natural Resources Subcommittee in support of inclusion of the Battle of Camden site (and Historic Camden) as a National Park or National Battlefield. [email protected], Utility Billing Frequently Asked Questions. Strong on enhancing Camden/County sports programs, she also has more than a passing interest in motorsports be it NASCAR, Formula One or Kershaw County's world-class testing and competition facility, Carolina Motorsports Park. Alfred Mae is an established leader within Kershaw County and Camden, South Carolina. Her platform is "Let's Build A Team-Together Everyone Achieves More". In the community, she is actively involved with Habitat for Humanity, Chairperson of the Board for United Way, Heritage Community Bank Advisory Board, Kershaw County IMPACT, Kershaw County Housing Partnership, Homeless Housing Committee, past President for Camden Rotary, the Municipal Association of South Carolina Board of Directors, steering committees for Human Development and Small Cities Council, Board of directors for the National Black Caucus for Local Elected Officials (NBC-LEO) and member of Women in Municipal Government (WIMG). The Camden Local Planning Panel is a panel of three independent expert members and a community member that determines certain development applications that involve conflicts of interest, contentious or sensitive development and development … For more information, including how to disable website content personalisation, see more about cookies. Camden Council. Mayor Moran is a life-long resident of Camden, he is a product of its public school system and is a former City employee. Aldermen, city officials and members of the media wore masks to Tuesday night's Camden City Council meeting and complied with United States Centers of Disease Control guidelines by socially distancing in the Business Incubator warehouse, where the meeting was held. She has a sincere understanding and empathy for the disenfranchised and intends to serve all people. Suzi Sale They are active members of First Baptist Church in Camden. Her work has led to several awards, including a SC Legislature Concurrent Resolution recognizing her work; a Martha Washington Medal by the National Society of the Sons of the American Revolution for her leadership in creating a Congressional-pending national heritage area and advocate for the protection of the Battle of Camden Site. They have one daughter, Kimberly who is married to Major Reginald Mosley (USAF), and one granddaughter Sydney Elise of Las Vegas, NV. Jeffrey Graham takes pride in his hometown. Council's Ward Map indicates the location of each Ward and the suburbs within that Ward.. On January 17, 2005 she was named Humanitarian of the Year for Kershaw County. Angus Taylor, MP191 Auburn Street, GoulburnPO Box 700, Goulburn NSW 2580Phone: 02 4822 2277Fax: 02 4822 1029Email: [email protected], Dr Mike Freelander, MP37 Queen Street, CampbelltownPO Box 88, Campbelltown NSW 2560Phone: 02 4620 0293Fax: 02 4620 4414Email: [email protected], Peter Sidgreaves, MP66 John Street, CamdenPhone: 02 4655 3333Fax: 02 4655 3325Email: [email protected], PO Box 183, Camden NSW 2570 ABN: 31 117 341 764, Blue-green algae bloom at Harrington Park Lake + 1 more alert, Public Swimming Pools and Tennis Facilities, Container Deposit Scheme - Return and Earn, Alcohol Free Zones and Alcohol Prohibited Areas.
110 Tl To Azn, Begusarai Vidhan Sabha Result 2015, Fishing Catawba River Morganton, Nc, Hikari Fancy Guppy 1kg, Tarmogoyf Foil Price, Hyundai Bold Font, Resilience Meditation Script, Money Slang Uk, Ferulic Acid Glucoside, Where Are Ice Cream Cones In Grocery Store, 2020 World Figure Skating Championships Schedule, The Best Approach To Promotion Budgeting Is, Play And Charge Kit Xbox One S, How To Make Yellow Paint More Mustard, How Did Bill Gates And Steve Jobs Changed The World, Jamie's Italy Tv Series, Chuchu Tv Itsy Bitsy Spider Nursery Rhyme Lyrics, Advantages Of Simmering, Davinci Coffee Syrup, Science Experiments Book, Hot 8 Brass Band Members,


text:
Home - Science - Bioinformatics
1-20 of 173 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Next 20
Bioinformatics: more books (100)
Bioinformatics For Dummies by Jean-Michel Claverie Ph. D., Cedric Notredame Ph.D., 2006-12-18
Beginning Perl for Bioinformatics by James Tisdall, 2001-10-15
Bioinformatics and Functional Genomics by Jonathan Pevsner, 2009-05-04
Introduction to Bioinformatics by Arthur Lesk, 2008-06-02
An Introduction to Bioinformatics Algorithms (Computational Molecular Biology) by Neil C. Jones, Pavel A. Pevzner, 2004-08-01
Building Bioinformatics Solutions: with Perl, R and MySQL by Conrad Bessant, Ian Shadforth, et all 2009-02-28
Python For Bioinformatics (Jones and Bartlett Series in Biomedical Informatics) by Jason Kinser, 2008-06-16
Bioinformatics: Sequence and Genome Analysis, Second Edition by David W. Mount, 2004-07-01
Understanding Bioinformatics by Marketa Zvelebil, Jeremy Baum, 2007-08-29
Developing Bioinformatics Computer Skills by Cynthia Gibas, Per Jambeck, 2001-04-15
Mastering Perl for Bioinformatics by James D. Tisdall, 2003-06
R Programming for Bioinformatics (Chapman & Hall/CRC Computer Science & Data Analysis) by Robert Gentleman, 2008-07-14
Structural Bioinformatics (Methods of Biochemical Analysis)
Statistical Methods in Bioinformatics: An Introduction (Statistics for Biology and Health) by Warren J. Ewens, Gregory R. Grant, 2004-12-21
European Bioinformatics Institute
British research center profiles its staff, conferences, publications, and databases. Find location details as well as project synopses. © Copyright European bioinformatics Institute 2002. All Rights and Trademarks Reserved.
http://www.ebi.ac.uk/
SIB - Presentation
teaching and service activities in the field of bioinformatics, in Switzerland with international collaborations.
http://www.isb-sib.ch/
Extractions: Contact us The SIB is an academic not-for-profit foundation established on March 30, 1998 whose mission is to promote research, the development of databanks and computer technologies, teaching and service activities in the field of bioinformatics, in Switzerland with international collaborations. SIB servers: ExPASy proteomics server Swiss node of EMBnet SIB databases: Eukaryotic Promoter Database (EPD) PROSITE Swiss-Prot and TrEMBL SWISS-2DPAGE ... SWISS-3DIMAGE SIB software: Melanie 4 SWISS-MODEL Swiss-PdbViewer SIB partners: Biozentrum, Basel
WIS Bioinformatics And Biological Computing
http://bioinfo.weizmann.ac.il/
The Bioinformatics Resource
Click here to go to The bioinformatics Resource
http://www.hgmp.mrc.ac.uk/CCP11
Extractions: What is TBR? TBR is the website of the CCP11project (Collaborative Computational Project 11). CCP11 was established to foster bioinformatics in the UK research community. Its purpose is to facilitate the transfer of knowledge and expertise through conferences, workshops, a newsletter and the use of the world wide web... read more HGMP-RC Training Courses The HGMP-RC creates and teaches courses tailored for wet lab biologists wishing to use computational tools to further their analyses. Designed to offer a general insight into current Bioinformatics, the introductory course brings participants up-to-speed with relevant in silico research tools. The theory behind commonly used algorithms will be explained before participants work through detailed examples using web based, publicly available software. Specialist courses are also offered for, amongst others, phylogeny, linkage and ACeDB read more
The Brutlag Bioinformatics Group
John Hopkins University searchable collection of genomic mapping data submitted by researchers worldwide.
http://motif.stanford.edu/
bioinformatics aims to publish high quality, peerreviewed, original scientific papers and excellent Category Science Biology bioinformatics Publications Journals Submit to bioinformatics. ISCB. Careers in bioinformatics. ABOUT THE JOURNAL,SUBSCRIPTIONS, ADVICE TO AUTHORS. EDITORS, ADVERTISING RATES, RELATED LINKS.
http://bioinformatics.oupjournals.org/
RSBS Bioinformatics Group Homepage
Group that researches molecular bioinformatics and biodiversity informatics lists its objectives and includes databases and contacts.
http://life.anu.edu.au/
Extractions: Research School of Biological Sciences, GPO Box 475, Canberra, ACT 2601,Australia Homepage See also the Research School of Biological Sciences website. Staff vacancies The Bioinformatics Group was formed in mid-1997. It researches both molecular bioinformatics and biodiversity informatics. Aims of the Bioinformatics Group To advance bioinformatic science by creating Mode of operation In its start-up phase the Bioinformatics Group is relatively small. Much of the Group's current research is done in collaboration with taxonomists, molecular biologists, ecologists, statisticians and computer scientists based elsewhere in the ANU or in other institutions (eg, CSIRO). We achieve synergistic effects by combining our strengths in computational biology with others' strengths in related fields. Postgraduate research As with the remainder of RSBS the Bioinformatics Group as such has no formal role in undergraduate teaching although individual members conduct courses within the Faculties of ANU. The Group offers postgraduate study (PhD by research, honours year BSc) in its areas of expertise.
Welcome To BioInform -- The Integrated Informatics News Source
Explore a New Yorkbased journal, published every other Monday, focused exclusively on current events in the global bioinformatics community. Oracle Hopes to Strike bioinformatics Gold with Embedded Data-Mining Tools
http://www.bioinform.com/
Visualisation For Bioinformatics
DNA microarray Visualisation Resources, Papers, Articles, Posters and Talks.
http://industry.ebi.ac.uk/~alan/VisSupp/
Extractions: N.B. The recommended URL to access this web page is http://industry.ebi.ac.uk/~alan/VisSupp/ About the visualisation project at the EBI For other details of visualisation at the EBI, see the homepage of Alan Robinson as well as the web page of large-scale gene expression and microarray links and resources For details of the EBI's work on DNA microarray visualisation - Please see the web pages of Alan Robinson and Alvis Brazma Course material from a workshop on "Visualisation for Bioinformatics" - including the analysis of gene expression and sequence data. The Visualisation Awareness Pages - A meta-index of Web sites. These pages aim to catalogue visualisation sites, applications, techniques and papers that may be of interest to the bioinfomratics and biological community. The start of a collection of visualisation and library components in Java Frontiers in Visualisation and Computer-Human Interaction '97 - A two day event over December 10th and 11th, 1997. This two day conference will provide an outstanding opportunity to hear some of the world's leading speakers in the related areas of computer-human interaction and visualisation. It will also provide an arena for professionals in the biosciences and pharmacology to meet with the leading graphics and interaction experts and to develop new ideas and synergies. Java p53 Mutation Viewer An integrated, modular system based using the widget approach has been developed for the visualisation and dynamic querying of mutation databases. The first prototype uses the
Bioinformatics.Org: Welcome To The Bioinformatics Organization!
A community focused on the freedom of information as it pertains to the biosciences.
http://bioinformatics.org/
Extractions: Software/Group People Google Not Logged In Login Join BiO (free!) The Organization About Us ... The Development Laboratory Project Hosting Software Map FTP Repository CVS Repository Mailing Lists ... Documentation The Research Laboratory Online Databases EST Clusters Immigrant Genes Leukemia Genes Pancreatic Cancer Genes Computer-based information visualization, or "infovis", centers around helping people explore or explain data by designing interactive software that exploits the capabilities of the human perceptual system. The central design challenge in infovis is designing a cognitively useful spatial mapping of a dataset that is not inherently spatial. There are many possible visual encodings, only a fraction of which are helpful for a given task. We draw on the intellectual history of several traditions, including computer graphics, human-computer interaction, cognitive psychology, semiotics, graphic design, statistical graphics, cartography, and art. The synthesis of relevant ideas from these fields with new methodologies and techniques made possible by interactive computation are critical for helping people keep pace with the torrents of data confronting them. One of the few resources increasing faster than the speed of computer hardware is the amount of data to be processed.
Bioinfo_glossary.html
Terms defined related to gene sequencing, informatics and applied molecular biology, from College of Staten Island, City University of New York (US). About 300 terms.
http://www.library.csi.cuny.edu/~davis/Bioinfo_326/bioinfo_glossary.html
Extractions: A B C D E ... Z Accession number An identifier supplied by the curators of the major biological databases upon submission of a novel entry that uniquely identifies that sequence (or other) entry. Active site The amino acid residues at the catalytic site of an enzyme. These residues provide the binding and activation energy needed to place the substrate into its transition state and bridge the energy barrier of the reaction undergoing catalysis Adenine A purine base found in DNA and RNA Agents Independent, autonomous, software modules that can search the Internet for data or content pertinent to a particular application, such as a gene, protein, or biological system. Agricultural biotechnology (AgBio) The application of rDNA technology to agriculturally important plants and organisms. Algorithm A series of steps defining a procedure or formula for solving a problem, that can be coded into a programming language and executed. Bioinformatics algorithms typically are used to process, store, analyze, visualize and make predictions from biological data. Alignment The result of a comparison of two or more gene or protein sequences in order to determine their degree of base or amino acid similarity. Sequence alignments are used to determine the similarity, homology, function or other degree of relatedness between two or more genes or gene products.
Bioinformatics -- Archive Of Issues By Date
http://bioinformatics.oupjournals.org/contents-by-date.0.shtml
Bioinformatics.Org: Bioinformatics FAQ
bioinformatics Frequently Asked Questions. Mail your questions to me, DamianCounsell, and I'll try to bring you answers. Definition of bioinformatics.
http://bioinformatics.org/faq/
Extractions: Software/Group People Google Not Logged In Login Join BiO (free!) The Organization About Us ... The Development Laboratory Project Hosting Software Map FTP Repository CVS Repository Mailing Lists ... Documentation The Research Laboratory Online Databases EST Clusters Immigrant Genes Leukemia Genes Pancreatic Cancer Genes New! Biodevelopers Mailing List Archives Other Resources Calendar jump straight to detailed contents Mail Please note that I cannot answer individual specific queries. I am not a careers adviser and . I hope, however, that the information here helps with your studies, career and work, and I am happy to tackle questions of general interest to all visitors to the site. I acknowledge the help of many other individuals in creating this part of the Bioinformatics.Org site. If you have contributed and I have forgotten to credit you, please
Digital Gene Technologies Home
Combines patented genomics technology with advanced bioinformatics to identify and determine anatomical distribution and expression patterns of the genes contained in any cell or tissue sample.
http://www.dgt.com/
GENBRAIN BIOSYSTEM NETWORK: From Biological Science To Biosystem Science
Research and links pertaining to transgenic animals, bioinformatics, genomic intelligence, and artificial biosystems.
http://www.BioSysNet.com/
Learning Methods For Data Exploration: Research Group
Analysis of functional genomics data, Construction of datadependent metrics for focusing data analysis on relevant or important aspects of the data.
http://www.cis.hut.fi/projects/mi/
Extractions: Home The group studies statistical models that are useful especially for exploratory data analysis, but also more generally in data mining, information visualization, and probabilistic modeling. The methods have close connections to machine learning, neural computation, and computational statistics. Data exploration is the first, data-driven phase of data analysis. Previously unknown dependencies are sought for in the data. The hypotheses discovered in the first phase are then verified in later stages of analysis. Our current focus is on a new approach to data analysis that we call learning metrics . The developed methods are used particularly in bioinformatics applications, but have also been used for information retrieval, analysis of bankruptcy risk, etc. BIOINFORMATICS
The bioinformatics Organization (bioinformatics.Org) will have a booth at the BioITWorld Conference Expo, March 25-27,
http://www.bioinformatics.org/
ExPASy - Biochemical Pathways
Digitized version of wall charts courtesy Boehringer Mannheim et al, divided into Metabolic Pathways and Cellular and Molecular Processes, maintained by the Swiss Institute of bioinformatics, Geneva, Switzerland.
http://www.expasy.ch/cgi-bin/search-biochem-index
Extractions: ExPASy Home page Site Map Search ExPASy Contact us ENZYME Search Swiss-Prot/TrEMBL Swiss-Prot/TrEMBL (full text) PROSITE SWISS-2DPAGE ENZYME NEWT Taxonomy HAMAP families ExPASy web site for This page gives access to the digitized version of the Roche Applied Science "Biochemical Pathways" wall chart. Please note that the German publishing company Spektrum Akademischer Verlag GmbH, Slevogtstrasse 3-5, 69126 Heidelberg owns the rights for commercial applications of the Biochemical Pathways. If you wish to use any of the information obtained from this site commercially please contact Ms. Ina Schibel at Spektrum Verlag for approval. For enquiries on how to obtain a paper copy of the wall chart, please contact Roche Applied Science directly, and do not email the ExPASy staff. Please enter one or more keyword(s) or partial word(s). For example, you may type Oxoacyl . You will then be given a list of all matching entries of the "Biochemical Pathways" wall chart. If you enter more than one keyword, only the entries matching all keywords will be listed. This list contains links to the ENZYME Database and, for each entry, links to all maps of "Biochemical Pathways" in which this entry appears.
Integrative BioInformatics - Home Page
Leveraging technology to bridge cell biology and genomics by providing computational biology and database technology software and consulting services for modeling complex biological problems faced by scientists in public and private research institutes, biotechnology companies, and universities.
http://www.integrativebioinformatics.com
Extractions: Leveraging Technology to bridge Cell Biology and Genomics Bioinformatics : Research, development or application of computational tools and approaches for expanding the use of biological, medical, behavioral or health data, including those to acquire, store, organize, archive, analyze or visualize such data. Computational Biology : The development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, behavioral, and social systems. (NIH Biomedical Information Science and Technology Initiative) Science is made up of facts just as a house is built up of stones, but a collection of facts is no more a science than a heap of stones is a house. H. Poincare Integrative BioInformatics is a biotech consulting firm with expertise in computational biology and database technology. We specialize in bringing our software solutions to bear on complex biological and data analysis problems faced by scientists in public and private research institutes, biotechnology companies, and universities.
UCLA Bioinformatics
Main web site for the UCLA bioinformatics program.Category Science Biology bioinformatics Research Groups in bioinformatics. bioinformatics is the study of the inherent structureof biological information and biological systems. It brings
http://www.bioinformatics.ucla.edu/
Extractions: Mission The UCLA Center for Bioinformatics is an interdepartmental faculty group that pursues fundamental research in bioinformatics and allied fields such as genomics and proteomics, and offers a graduate curriculum in bioinformatics. The Center fosters faculty research collaborations, provides graduate training fellowships, and operates a Bioinformatics User Lab for UCLA researchers. The Center is composed of more than 15 faculty laboratories active in bioinformatics research, from the Medical School, Life Sciences, Physical Sciences and Engineering. Faculty Research The faculty of the UCLA Center for Bioinformatics engage in a wide variety of research topics in bioinformatics, genomics and proteomics. The Center includes more than 15 laboratories affiliated with departments such as Chemistry and Biochemistry, Computer Science, Human Genetics, and Statistics. Detailed faculty research descriptions are available at


with a secure check out process through PayPal.
A paypal account is NOT required to process your order.
Please specify print color and shirt color. We will try our best to create your combo.
We will have more designs posted soon!


text:
"""
This is a simple file reader
And prints all the lines that starts with from:
"""
fName = raw_input("Enter the file name: ")
try:
	fhand = open(fName)
except:
	print "'%s' file does not exist!!!" % fName
	exit()
filWord = raw_input("Filter for line starting with word (Please provide the word. Note: its case sensitive)??")
dup_chk = raw_input("Remove duplicates (y/n)")

lCount = 0
lResults = ''
for line in fhand:
	lCount = lCount + 1
	#line = line.rstrip()
	if line.startswith(filWord):
		#Check for duplicates here
		if (dup_chk == 'y' or dup_chk == 'Y'):
			if lResults.find(line) == -1:
				lResults = lResults + line
		else:
			lResults = lResults + line
fopHand = open("output.txt", "w")
fopHand.write(lResults)
fopHand.close()
print lResults
print "Total number of lines in the file is %d" % lCount

redpajama_set_name: RedPajamaGithub


300 f2.8 or 300 f4 or 70-200 f2.8 for 1 day(ish). It just happens to be grand final day (Sat 27/Sep through to Sun 28/Sep), but am not needing it for the Grand Final. The wife and I have got an overnight trip to the Werribee Zoo planned (Slumber Safari) and are looking for a better lens than what I have in my kit so far.
Borges Imaging rent them out, 70-210 VR for $66 / day.


text:
Q: Custom row cell in SQL So I'm looking to use a custom row cell to label my data.

Basketball
Baseball
Golf
Cost

1
0
0
$50

0
1
0
$75

1
0
1
$150

0
1
1
$225

The table I have is above. What I'm trying to do is below:
OUTPUT:

Sport
Cost

Basketball
200

Baseball
300

Golf
375

I can get the sum of each sport but I'm having trouble making an alias for each sport on the output table (The first column)
How would I go about that? I've done an alias for a column header, but never for a row cell.
Thanks in advance!

A: select   game
        ,sum(cost*flg) as cost

from t
     cross join lateral (
     values
            (basketball, 'basketball')
           ,(baseball, 'baseball')
           ,(golf, 'golf')
                        ) t2(flg, game)
group by game

game
cost

golf
375

baseball
300

basketball
200

Fiddle

A: Use a UNION with different WHERE conditions:
select sport, sum(cost)
from
(
  select 'Basketball' as sport, cost
  from the_table
  where basketball = 1
  union all
  select 'Baseball', cost
  from the_table
  where baseball = 1
  union all
  select 'Golf', cost
  from the_table
  where golf = 1
) t
group by sport;


text:
Subhadeep Chatterjee is an Indian molecular biologist and a scientist at the Centre for DNA Fingerprinting and Diagnostics (CDFD). A member of Guha Research Conference, he is known for his studies on plant-microbe interactions and heads the Lab of Plant-Microbe Interactions at CDFD where he hosts several researchers.

Chatterjee, after earning an M.Sc. in Biotechnology from Guru Nanak Dev University, Amritsar, did his doctoral research at the laboratory of Ramesh Venkata Sonti of the Centre for Cellular and Molecular Biology (CCMB), Hyderabad. His post-doctoral work was at the laboratory of Steven E. Lindow at the University of California, Berkeley. He is known to have carried out extensive research on plant- microbe interaction system and has published a number of articles, ResearchGate, an online repository of scientific articles has listed 52 of them. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2017/18.

Subhadeep Chatterjee was awarded the Shanti Swarup Bhatnagar Prize for Science and Technology, the highest science award in India, for the year 2020 in biological sciences category.

Selected bibliography

See also

 Xanthomonas
 Siderophore
 Xanthoferrin

Notes

References

External links

Indian scientific authors
Year of birth missing (living people)
N-BIOS Prize recipients
Indian molecular biologists
Guru Nanak Dev University alumni
University of California, Berkeley alumni
People from West Bengal
Living people
Scientists from West Bengal

redpajama_set_name: RedPajamaWikipedia